mp:V9.1.0 kwalificatie voorschrift addendum: verschil tussen versies

Uit informatiestandaarden
Ga naar: navigatie, zoeken
k (Tekst vervangen - "{{#customtitle:" door "{{DISPLAYTITLE:")
(21 tussenliggende versies door 2 gebruikers niet weergegeven)
Regel 1: Regel 1:
  
 
__NUMBEREDHEADINGS__
 
__NUMBEREDHEADINGS__
{{#customtitle:Sturen medicatievoorschrift 9.1.0: addendum inhoudelijke gegevens kwalificatie}}
+
{{DISPLAYTITLE:Sturen medicatievoorschrift 9.1.0: addendum inhoudelijke gegevens kwalificatie}}
  
 
=Addenda voor inhoudelijke gegevens=
 
=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's ==
+
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==
  
 
=== Scenarioset 1===
 
=== Scenarioset 1===
<section begin=overview-1 />
+
<section begin=overview-VOS-1 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</span></div>|| MBH_910_start_eind|| MBH_910_start_eind_MA|| MBH_910_start_eind_VV
+
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</span></div>|| MBH_910_start_eind|| MBH_910_start_eind_MA|| MBH_910_start_eind_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_910_start_duur|| MBH_910_start_duur_MA|| MBH_910_start_duur_VV
+
|1.2a*||Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_910_start_duur|| MBH_910_start_duur_MA|| MBH_910_start_duur_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)</span></div>|| MBH_910_start_duur2|| MBH_910_start_duur2_MA|| MBH_910_start_duur2_VV
+
|1.2b*||Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)</span></div>|| MBH_910_start_duur2|| MBH_910_start_duur2_MA|| MBH_910_start_duur2_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV
+
|1.3|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Extra VV onder bestaande MA</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: maak het VV aan bij de bestaande MA uit scenario 1.3</span></div>|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV_extraVVbestaandeMA
+
|1.4|| Maak screenshot(s) waaruit blijkt dat het extra VV gemaakt wordt/behoort bij de eerdere MA.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Extra VV onder bestaande MA</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: VV bij de bestaande MA uit scenario 1.3</span></div>|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV_extraVVbestaandeMA
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.5|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_910_dosis_stuks|| MBH_910_dosis_stuks_MA|| MBH_910_dosis_stuks_VV
 
|1.5|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_910_dosis_stuks|| MBH_910_dosis_stuks_MA|| MBH_910_dosis_stuks_VV
 
|}
 
|}
<section end=overview-1 />
+
<section end=overview-VOS-1 />
 +
 
 
=== Scenarioset 2===
 
=== Scenarioset 2===
<section begin=overview-2 />
+
<section begin=overview-VOS-2 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende instructie (MA)</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA|| MBH_910_aanvullendeinstructie_VV
+
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende instructie (MA)</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA|| MBH_910_aanvullendeinstructie_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Toelichting (MA), toelichting (VV)</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA|| MBH_910_toelichting_VV
+
|2.2|| Maak screenshot(s) waaruit blijkt dat bij zowel de MA als VV een 'toelichting' ingevoerd kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Toelichting (MA), toelichting (VV)</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA|| MBH_910_toelichting_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Maak een screenshot van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Reden van voorschrijven (MA)</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA|| MBH_910_redenvanvoorschrijven_VV
+
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Reden van voorschrijven (MA)</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA|| MBH_910_redenvanvoorschrijven_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV),&nbsp;</span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA), meerdere MBHs in één voorschrift</span></div>|| MBH_910_aanvullendeinformatiewensen<br>MBH_910_Toedieningsweg|| MBH_910_aanvullendeinformatiewensen_MA<br>MBH_910_Toedieningsweg_MA|| MBH_910_aanvullendeinformatiewensen_VV<br>MBH_910_Toedieningsweg_VV
+
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (MA) en 'aanvullende wensen' (VV) zichtbaar zijn|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV),&nbsp;</span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA), meerdere MBHs in één voorschrift</span></div>|| MBH_910_aanvullendeinformatiewensen<br>MBH_910_Toedieningsweg|| MBH_910_aanvullendeinformatiewensen_MA<br>MBH_910_Toedieningsweg_MA|| MBH_910_aanvullendeinformatiewensen_VV<br>MBH_910_Toedieningsweg_VV
 
|}
 
|}
<section end=overview-2 />
+
<section end=overview-VOS-2 />
 
=== Scenarioset 3===
 
=== Scenarioset 3===
<section begin=overview-3 />
+
<section begin=overview-VOS-3 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-medicatieafspraak, met reden staken</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: stop de medicatieafspraak van scenario 2.1</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA_staken||  
+
|3.1|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-medicatieafspraak, met reden staken</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: stop medicatieafspraak van scenario 2.1</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA_staken||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijzig de medicatieafspraak van scenario 2.2</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA_wijzigingmetVV<br>MBH_910_toelichting_MA_techstaken|| MBH_910_toelichting_VV_extra
+
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.2</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA_wijzigingmetVV<br>MBH_910_toelichting_MA_techstaken|| MBH_910_toelichting_VV_extra
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijzig de medicatieafspraak van scenario 2.3</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV<br>MBH_910_redenvanvoorschrijven_MA_techstaken||  
+
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.3</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV<br>MBH_910_redenvanvoorschrijven_MA_techstaken||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|3.4 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken medicatieafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreek de medicatieafspraak van scenario 2.4</span></div>|| MBH_910_aanvullendeinformatiewensen|| MBH_910_aanvullendeinformatiewensen_MA_onderbreken||  
+
|3.4 optioneel|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken medicatieafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking medicatieafspraak van scenario 2.4</span></div>|| MBH_910_aanvullendeinformatiewensen|| MBH_910_aanvullendeinformatiewensen_MA_onderbreken||  
 
|}
 
|}
<section end=overview-3 />
+
<section end=overview-VOS-3 />
 
=== Scenarioset 4===
 
=== Scenarioset 4===
<section begin=overview-4 />
+
<section begin=overview-VOS-4 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|4.1*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (zonder eigen id)</span></div>|| MBH_910_Lengte_Gewicht|| MBH_910_Lengte_Gewicht_MA_1|| MBH_910_Lengte_Gewicht_VV_1
+
|4.1*|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden voor een voorschrift|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (zonder eigen id)</span></div>|| MBH_910_Lengte_Gewicht|| MBH_910_Lengte_Gewicht_MA_1|| MBH_910_Lengte_Gewicht_VV_1
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|4.2*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (als persistente bouwstenen)</span></div>|| MBH_910_Lengte_Gewicht_Persistent|| MBH_910_Lengte_Gewicht_Persistent_MA|| MBH_910_Lengte_Gewicht_Persistent_VV
+
|4.2*|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden voor een voorschrift|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (als persistente bouwstenen)</span></div>|| MBH_910_Lengte_Gewicht_Persistent|| MBH_910_Lengte_Gewicht_Persistent_MA|| MBH_910_Lengte_Gewicht_Persistent_VV
 
|}
 
|}
<section end=overview-4 />
+
<section end=overview-VOS-4 />
 
=== Scenarioset 5===
 
=== Scenarioset 5===
<section begin=overview-5 />
+
<section begin=overview-VOS-5 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|5.1*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (zonder eigen id)</span></div>|| MBH_910_Nierfunctie|| MBH_910_Nierfunctie_MA_1|| MBH_910_Nierfunctie_VV_1
+
|5.1*|| Maak screenshot(s) waarin zichtbaar is dat er een nierfunctiewaarde van toepassing is voor dit voorschrift (aanvinken/invoeren o.i.d) || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (zonder eigen id)</span></div>|| MBH_910_Nierfunctie|| MBH_910_Nierfunctie_MA_1|| MBH_910_Nierfunctie_VV_1
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|5.2*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (als persistente bouwsteen)</span></div>|| MBH_910_Nierfunctie_Persistent|| MBH_910_Nierfunctie_Persistent_MA|| MBH_910_Nierfunctie_Persistent_VV
+
|5.2*|| Maak screenshot(s) waarin zichtbaar is dat er een nierfunctiewaarde van toepassing is voor dit voorschrift (aanvinken/invoeren o.i.d) || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (als persistente bouwsteen)</span></div>|| MBH_910_Nierfunctie_Persistent|| MBH_910_Nierfunctie_Persistent_MA|| MBH_910_Nierfunctie_Persistent_VV
 
|}
 
|}
<section end=overview-5 />
+
<section end=overview-VOS-5 />
 
=== Scenarioset 6===
 
=== Scenarioset 6===
<section begin=overview-6 />
+
<section begin=overview-VOS-6 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
Regel 95: Regel 96:
 
|6.6 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (2)</span></div>|| MBH_910_variabelehoeveelheid2|| MBH_910_variabelehoeveelheid2_MA|| MBH_910_variabelehoeveelheid2_VV
 
|6.6 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (2)</span></div>|| MBH_910_variabelehoeveelheid2|| MBH_910_variabelehoeveelheid2_MA|| MBH_910_variabelehoeveelheid2_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.7a*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Ja"</span></div>|| MBH_910_tijdstippen|| MBH_910_tijdstippen_MA|| MBH_910_tijdstippen_VV
+
|6.7a*|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip flexibel is of exact gevolgd moet worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Ja"</span></div>|| MBH_910_tijdstippen|| MBH_910_tijdstippen_MA|| MBH_910_tijdstippen_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.7b*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Nee"</span></div>|| MBH_910_tijdstippenExact|| MBH_910_tijdstippenExact_MA || MBH_910_tijdstippenExact_VV  
 
|6.7b*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Nee"</span></div>|| MBH_910_tijdstippenExact|| MBH_910_tijdstippenExact_MA || MBH_910_tijdstippenExact_VV  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.8 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Weekdagen</span></div>|| MBH_910_weekdagen|| MBH_910_weekdagen_MA|| MBH_910_weekdagen_VV
+
|6.8 optioneel|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Weekdagen</span></div>|| MBH_910_weekdagen|| MBH_910_weekdagen_MA|| MBH_910_weekdagen_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.9*|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_910_dagdeel|| MBH_910_dagdeel_MA|| MBH_910_dagdeel_VV
+
|6.9*|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_910_dagdeel|| MBH_910_dagdeel_MA|| MBH_910_dagdeel_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.10 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Cyclisch schema</span></div>|| MBH_910_cyclischschema|| MBH_910_cyclischschema_MA|| MBH_910_cyclischschema_VV
+
|6.10 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Cyclisch schema</span></div>|| MBH_910_cyclischschema|| MBH_910_cyclischschema_MA|| MBH_910_cyclischschema_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.11 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Afbouw schema en doseerduur</span></div>|| MBH_910_afbouwschema|| MBH_910_afbouwschema_MA|| MBH_910_afbouwschema_VV
+
|6.11 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Afbouw schema en doseerduur</span></div>|| MBH_910_afbouwschema|| MBH_910_afbouwschema_MA|| MBH_910_afbouwschema_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.12 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele frequentie en maximum</span></div>|| MBH_910_variabelefrequentieenmaximum|| MBH_910_variabelefrequentieenmaximum_MA|| MBH_910_variabelefrequentieenmaximum_VV
+
|6.12 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid en maximum</span></div>|| MBH_910_variabelehoeveelheidenmaximum|| MBH_910_variabelehoeveelheidenmaximum_MA|| MBH_910_variabelehoeveelheidenmaximum_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.13 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningssnelheid</span></div>|| MBH_910_toedieningssnelheid|| MBH_910_toedieningssnelheid_MA|| MBH_910_toedieningssnelheid_VV
 
|6.13 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningssnelheid</span></div>|| MBH_910_toedieningssnelheid|| MBH_910_toedieningssnelheid_MA|| MBH_910_toedieningssnelheid_VV
Regel 113: Regel 114:
 
|6.14 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningsduur</span></div>|| MBH_910_toedieningsduur|| MBH_910_toedieningsduur_MA|| MBH_910_toedieningsduur_VV
 
|6.14 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningsduur</span></div>|| MBH_910_toedieningsduur|| MBH_910_toedieningsduur_MA|| MBH_910_toedieningsduur_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zo nodig</span></div>|| MBH_910_zonodig|| MBH_910_zonodig_MA|| MBH_910_zonodig_VV
+
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zo nodig</span></div>|| MBH_910_zonodig|| MBH_910_zonodig_MA|| MBH_910_zonodig_VV
 
|}
 
|}
<section end=overview-6 />
+
<section end=overview-VOS-6 />
 
=== Scenarioset 7===
 
=== Scenarioset 7===
<section begin=overview-7 />
+
<section begin=overview-VOS-7 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|7.1 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_910_magistraalalleingredienten|| MBH_910_magistraalalleingredienten_MA|| MBH_910_magistraalalleingredienten_VV
+
|7.1 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_910_magistraalalleingredienten|| MBH_910_magistraalalleingredienten_MA|| MBH_910_magistraalalleingredienten_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_910_magistraalactieveingredient|| MBH_910_magistraalactieveingredient_MA|| MBH_910_magistraalactieveingredient_VV
+
|7.2 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_910_magistraalactieveingredient|| MBH_910_magistraalactieveingredient_MA|| MBH_910_magistraalactieveingredient_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|7.3 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">90 miljoen nummer</span></div>|| MBH_910_magistraal90miljoennr|| MBH_910_magistraal90miljoennr_MA|| MBH_910_magistraal90miljoennr_VV
+
|7.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">90 miljoen nummer</span></div>|| MBH_910_magistraal90miljoennr|| MBH_910_magistraal90miljoennr_MA|| MBH_910_magistraal90miljoennr_VV
 
|}
 
|}
<section end=overview-7 />
+
<section end=overview-VOS-7 />
 
=== Scenarioset 8===
 
=== Scenarioset 8===
<section begin=overview-8 />
+
<section begin=overview-VOS-8 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|8.1|| Maak screenshots na het versturen van het voorschrift waarin de samenhang van de Medicatiebouwstenen binnen de MBH zichtbaar is.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Verstrekkingsverzoek onder andermans medicatieafspraak</span></div>|| MBH_910_VVandermansMA|| MBH_910_VVandermansMA_MA|| MBH_910_VVandermansMA_VV
+
|8.1|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Verstrekkingsverzoek onder andermans medicatieafspraak</span></div>|| MBH_910_VVandermansMA|| MBH_910_VVandermansMA_MA|| MBH_910_VVandermansMA_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|8.2|| Maak screenshots na het versturen van het voorschrift waarin de samenhang van de Medicatiebouwstenen binnen de MBH zichtbaar is.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stoppen andermans medicatieafspraak</span></div>|| MBH_910_stakenandermansMA|| MBH_910_stakenandermansMA_MA2||  
+
|8.2|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stoppen andermans medicatieafspraak</span></div>|| MBH_910_stakenandermansMA|| MBH_910_stakenandermansMA_MA2||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|8.3 optioneel|| Maak screenshots na het versturen van het voorschrift waarin de samenhang van de Medicatiebouwstenen binnen de MBH zichtbaar is.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Onderbreken andermans medicatieafspraak</span></div>|| MBH_910_onderbrekenandermansMA|| MBH_910_onderbrekenandermansMA_MA2||  
+
|8.3 optioneel|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Onderbreken andermans medicatieafspraak</span></div>|| MBH_910_onderbrekenandermansMA|| MBH_910_onderbrekenandermansMA_MA2||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|8.4|| Maak screenshots na het versturen van het voorschrift waarin de samenhang van de Medicatiebouwstenen binnen de MBH zichtbaar is.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Wijzigen andermans medicatieafspraak</span></div>|| MBH_910_wijzigenandermansMA|| MBH_910_wijzigenandermansMA_MA_techstaken<br>MBH_910_wijzigenandermansMA_MA2||  
+
|8.4|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Wijzigen andermans medicatieafspraak</span></div>|| MBH_910_wijzigenandermansMA|| MBH_910_wijzigenandermansMA_MA_techstaken<br>MBH_910_wijzigenandermansMA_MA2||  
 
|}
 
|}
<section end=overview-8 />
+
<section end=overview-VOS-8 />
 
=== Scenarioset 9===
 
=== Scenarioset 9===
<section begin=overview-9 />
+
<section begin=overview-VOS-9 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|9.1a optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_start_eind|| MBH_910_logistiekeverbruiksperiode_start_eind_MA|| MBH_910_logistiekeverbruiksperiode_start_eind_VV
+
|9.1a optioneel|| Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_start_eind|| MBH_910_logistiekeverbruiksperiode_start_eind_MA|| MBH_910_logistiekeverbruiksperiode_start_eind_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
 
|9.1b optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_eind|| MBH_910_logistiekeverbruiksperiode_eind_MA|| MBH_910_logistiekeverbruiksperiode_eind_VV
 
|9.1b optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_eind|| MBH_910_logistiekeverbruiksperiode_eind_MA|| MBH_910_logistiekeverbruiksperiode_eind_VV
Regel 156: Regel 157:
 
|9.1c optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_duur_dagen|| MBH_910_logistiekeverbruiksperiode_duur_dagen_MA|| MBH_910_logistiekeverbruiksperiode_duur_dagen_VV
 
|9.1c optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_duur_dagen|| MBH_910_logistiekeverbruiksperiode_duur_dagen_MA|| MBH_910_logistiekeverbruiksperiode_duur_dagen_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|9.2 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Herhalingen</span></div>|| MBH_910_herhalingen|| MBH_910_herhalingen_MA|| MBH_910_herhalingen_VV
+
|9.2 optioneel|| Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Herhalingen</span></div>|| MBH_910_herhalingen|| MBH_910_herhalingen_MA|| MBH_910_herhalingen_VV
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
|9.3 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Afleverlocatie</span></div>|| MBH_910_afleverlocatie|| MBH_910_afleverlocatie_MA|| MBH_910_afleverlocatie_VV
+
|9.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Afleverlocatie</span></div>|| MBH_910_afleverlocatie|| MBH_910_afleverlocatie_MA|| MBH_910_afleverlocatie_VV
 
|}
 
|}
<section end=overview-9 />
+
<section end=overview-VOS-9 />
 
=== Scenarioset 10===
 
=== Scenarioset 10===
<section begin=overview-10 />
+
<section begin=overview-VOS-10 />
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
Regel 171: Regel 172:
 
|10.2 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">ZI-nr geneesmiddel</span></div>|| MBH_910_ZINRvoorschrijven|| MBH_910_ZINRvoorschrijven_MA|| MBH_910_ZINRvoorschrijven_VV
 
|10.2 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">ZI-nr geneesmiddel</span></div>|| MBH_910_ZINRvoorschrijven|| MBH_910_ZINRvoorschrijven_MA|| MBH_910_ZINRvoorschrijven_VV
 
|}
 
|}
<section end=overview-10 />
+
<section end=overview-VOS-10 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_eind==
+
== Overzicht van scenario's voor ontvangend systeem ==
<section begin=mv-Scenarioset1-MBH_910_start_eind-1 /><section begin=patient-mv-Scenarioset1-MBH_910_start_eind-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
  
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
=== Scenarioset 1===
|colspan="2"|Naamgegevens
+
<section begin=overview-VOO-1 />
|style="background-color: white;"|A. van de XXX_Boschman
+
{| class="wikitable"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="2"|Identificatienummer
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|style="background-color: white;"|999912100 [BSN]
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|1.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</span></div>|| MBH_910_start_eind|| MBH_910_start_eind_MA|| MBH_910_start_eind_VV
|colspan="2"|Geboortedatum
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: white;"|8 jan 1964
+
|1.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_910_start_duur|| MBH_910_start_duur_MA|| MBH_910_start_duur_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Geslacht
+
|1.2b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)</span></div>|| MBH_910_start_duur2|| MBH_910_start_duur2_MA|| MBH_910_start_duur2_VV
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|-style="vertical-align:top;|style="background-color: white;"
|}<section end=patient-mv-Scenarioset1-MBH_910_start_eind-1 /><section begin=mbhs-mv-Scenarioset1-MBH_910_start_eind-1 />
+
|1.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV
==== Scenario 1.1* - MBH_910_start_eind====
+
|-style="vertical-align:top;|style="background-color: white;"
 
+
|1.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Extra VV onder bestaande MA</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: VV bij de bestaande MA uit scenario 1.3</span></div>|| MBH_910_chronisch|| MBH_910_chronisch_MA|| MBH_910_chronisch_VV_extraVVbestaandeMA
{| class="wikitable" width="85%"
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|1.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_910_dosis_stuks|| MBH_910_dosis_stuks_MA|| MBH_910_dosis_stuks_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
+
|}
|colspan="5" width="25%"| Gegevenselement
+
<section end=overview-VOO-1 />
|| Waarde
+
=== Scenarioset 2===
 
+
<section begin=overview-VOO-2 />
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
{| class="wikitable"
|colspan="5"|Identificatie
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|style="background-color: white;"|MBH_910_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="5"|Afspraak datum tijd
+
|2.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende instructie (MA)</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA|| MBH_910_aanvullendeinstructie_VV
|style="background-color: white;"|T om 11:20:00 uur
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;
+
|2.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Toelichting (MA), toelichting (VV)</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA|| MBH_910_toelichting_VV
|colspan="5"|Gebruiksperiode
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen''
+
|2.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Reden van voorschrijven (MA)</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA|| MBH_910_redenvanvoorschrijven_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|rowspan="3"|
+
|2.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV),&nbsp;</span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA), meerdere MBHs in één voorschrift</span></div>|| MBH_910_aanvullendeinformatiewensen<br>MBH_910_Toedieningsweg|| MBH_910_aanvullendeinformatiewensen_MA<br>MBH_910_Toedieningsweg_MA|| MBH_910_aanvullendeinformatiewensen_VV<br>MBH_910_Toedieningsweg_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|}
|colspan="4"|Ingangsdatum
+
<section end=overview-VOO-2 />
|style="background-color: white;"|T om 00:00:00 uur
+
=== Scenarioset 3===
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
<section begin=overview-VOO-3 />
|colspan="4"|Einddatum
+
{| class="wikitable"
|style="background-color: white;"|T + 5 dagen om 23:59:59 uur
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|colspan="6"|Voorschrijver
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|3.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-medicatieafspraak, met reden staken</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: stop medicatieafspraak van scenario 2.1</span></div>|| MBH_910_aanvullendeinstructie|| MBH_910_aanvullendeinstructie_MA_staken||  
|rowspan="11"|
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|3.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.2</span></div>|| MBH_910_toelichting|| MBH_910_toelichting_MA_wijzigingmetVV<br>MBH_910_toelichting_MA_techstaken|| MBH_910_toelichting_VV_extra
|colspan="5"|Zorgverlener
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|3.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.3</span></div>|| MBH_910_redenvanvoorschrijven|| MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV<br>MBH_910_redenvanvoorschrijven_MA_techstaken||
|rowspan="9"|
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|3.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken medicatieafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking medicatieafspraak van scenario 2.4</span></div>|| MBH_910_aanvullendeinformatiewensen|| MBH_910_aanvullendeinformatiewensen_MA_onderbreken||
|colspan="3"|Zorgverlener identificatienummer
+
|}
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
+
<section end=overview-VOO-3 />
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
=== Scenarioset 4===
|colspan="3"|Naamgegevens
+
<section begin=overview-VOO-4 />
|style="background-color: white;"|Peter van  Pulver
+
{| class="wikitable"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3"|Specialisme
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;" 
+
|4.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (zonder eigen id)</span></div>|| MBH_910_Lengte_Gewicht|| MBH_910_Lengte_Gewicht_MA_1|| MBH_910_Lengte_Gewicht_VV_1
|colspan="4"|Zorgaanbieder
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|4.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (als persistente bouwstenen)</span></div>|| MBH_910_Lengte_Gewicht_Persistent|| MBH_910_Lengte_Gewicht_Persistent_MA|| MBH_910_Lengte_Gewicht_Persistent_VV
|rowspan="4"|
+
|}
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
<section end=overview-VOO-4 />
|colspan="2"|Zorgaanbieder identificatienummer
+
=== Scenarioset 5===
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
+
<section begin=overview-VOO-5 />
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
{| class="wikitable"
|colspan="2"|Organisatie naam
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Adresgegevens
+
|5.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (zonder eigen id)</span></div>|| MBH_910_Nierfunctie|| MBH_910_Nierfunctie_MA_1|| MBH_910_Nierfunctie_VV_1
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|5.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met Nierfunctiewaarde (als persistente bouwsteen)</span></div>|| MBH_910_Nierfunctie_Persistent|| MBH_910_Nierfunctie_Persistent_MA|| MBH_910_Nierfunctie_Persistent_VV
|colspan="5"|Geneesmiddel - primaire code
+
|}
|style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK')
+
<section end=overview-VOO-5 />
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
=== Scenarioset 6===
|colspan="5"|Geneesmiddel - generiekere code
+
<section begin=overview-VOO-6 />
|style="background-color: white;"|METOCLOPRAMIDE 20MG ZETPIL (code = '63630' in codeSystem 'G-Standaard GPK')
+
{| class="wikitable"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6"|Gebruiksinstructie
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|rowspan="4"|
+
|6.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Variabele frequentie</span></div>|| MBH_910_variabelefrequentie|| MBH_910_variabelefrequentie_MA|| MBH_910_variabelefrequentie_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="4"|Omschrijving
+
|6.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Interval</span></div>|| MBH_910_interval|| MBH_910_interval_MA|| MBH_910_interval_VV
|style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Rectaal
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|6.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (1)</span></div>|| MBH_910_variabelehoeveelheid|| MBH_910_variabelehoeveelheid_MA|| MBH_910_variabelehoeveelheid_VV
|colspan="4"|Toedieningsweg
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|6.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zonder keerdosis</span></div>|| MBH_910_zonderkeerdosis|| MBH_910_zonderkeerdosis_MA|| MBH_910_zonderkeerdosis_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="4"|Doseerinstructie
+
|6.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Bijzondere keerdosis</span></div>|| MBH_910_bijzonderekeerdosis|| MBH_910_bijzonderekeerdosis_MA|| MBH_910_bijzonderekeerdosis_VV
|style="background-color: white;"|1 maal per dag 1 stuk
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|6.6|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (2)</span></div>|| MBH_910_variabelehoeveelheid2|| MBH_910_variabelehoeveelheid2_MA|| MBH_910_variabelehoeveelheid2_VV
|colspan="5"|MBH identificatie
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: white;"|MBH_910_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|6.7a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Ja"</span></div>|| MBH_910_tijdstippen|| MBH_910_tijdstippen_MA|| MBH_910_tijdstippen_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.7b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen IsFlexibel "Nee"</span></div>|| MBH_910_tijdstippenExact|| MBH_910_tijdstippenExact_MA || MBH_910_tijdstippenExact_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.8|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Weekdagen</span></div>|| MBH_910_weekdagen|| MBH_910_weekdagen_MA|| MBH_910_weekdagen_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.9|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_910_dagdeel|| MBH_910_dagdeel_MA|| MBH_910_dagdeel_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.10|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Cyclisch schema</span></div>|| MBH_910_cyclischschema|| MBH_910_cyclischschema_MA|| MBH_910_cyclischschema_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.11|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Afbouw schema en doseerduur</span></div>|| MBH_910_afbouwschema|| MBH_910_afbouwschema_MA|| MBH_910_afbouwschema_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.12|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid en maximum</span></div>|| MBH_910_variabelehoeveelheidenmaximum|| MBH_910_variabelehoeveelheidenmaximum_MA|| MBH_910_variabelehoeveelheidenmaximum_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.13|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningssnelheid</span></div>|| MBH_910_toedieningssnelheid|| MBH_910_toedieningssnelheid_MA|| MBH_910_toedieningssnelheid_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.14|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningsduur</span></div>|| MBH_910_toedieningsduur|| MBH_910_toedieningsduur_MA|| MBH_910_toedieningsduur_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.15|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zo nodig</span></div>|| MBH_910_zonodig|| MBH_910_zonodig_MA|| MBH_910_zonodig_VV
 +
|}
 +
<section end=overview-VOO-6 />
 +
=== Scenarioset 7===
 +
<section begin=overview-VOO-7 />
 +
{| class="wikitable"
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|7.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_910_magistraalalleingredienten|| MBH_910_magistraalalleingredienten_MA|| MBH_910_magistraalalleingredienten_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|7.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_910_magistraalactieveingredient|| MBH_910_magistraalactieveingredient_MA|| MBH_910_magistraalactieveingredient_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|7.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">90 miljoen nummer</span></div>|| MBH_910_magistraal90miljoennr|| MBH_910_magistraal90miljoennr_MA|| MBH_910_magistraal90miljoennr_VV
 
|}
 
|}
{| class="wikitable" width="85%"
+
<section end=overview-VOO-7 />
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Verstrekkingsverzoek
+
=== Scenarioset 8===
|-style="background-color: #1F497D;; color: white; text-align:left;"  
+
<section begin=overview-VOO-8 />
|colspan="2" width="25%"| Gegevenselement
+
{| class="wikitable"
|| Waarde
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Identificatie
+
|8.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Verstrekkingsverzoek onder andermans medicatieafspraak</span></div>|| MBH_910_VVandermansMA|| MBH_910_VVandermansMA_MA|| MBH_910_VVandermansMA_VV
|style="background-color: white;"|MBH_910_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|8.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stoppen andermans medicatieafspraak</span></div>|| MBH_910_stakenandermansMA|| MBH_910_stakenandermansMA_MA2||  
|colspan="2"|Datum
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: white;"|T om 11:20:00 uur
+
|8.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Onderbreken andermans medicatieafspraak</span></div>|| MBH_910_onderbrekenandermansMA|| MBH_910_onderbrekenandermansMA_MA2||  
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Auteur
+
|8.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Wijzigen andermans medicatieafspraak</span></div>|| MBH_910_wijzigenandermansMA|| MBH_910_wijzigenandermansMA_MA_techstaken<br>MBH_910_wijzigenandermansMA_MA2||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|}
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
<section end=overview-VOO-8 />
|colspan="2"|Te verstrekken hoeveelheid
+
=== Scenarioset 9===
|style="background-color: white;"|5 stuks
+
<section begin=overview-VOO-9 />
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
{| class="wikitable"
|colspan="2"|Geneesmiddel - primaire code
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
|style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK')
+
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Geneesmiddel - generiekere code
+
|9.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_start_eind|| MBH_910_logistiekeverbruiksperiode_start_eind_MA|| MBH_910_logistiekeverbruiksperiode_start_eind_VV
|style="background-color: white;"|METOCLOPRAMIDE 20MG ZETPIL (code = '63630' in codeSystem 'G-Standaard GPK')
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|9.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_eind|| MBH_910_logistiekeverbruiksperiode_eind_MA|| MBH_910_logistiekeverbruiksperiode_eind_VV
|colspan="2"|Beoogd verstrekker
+
|-style="vertical-align:top;|style="background-color: white;"
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|9.1c|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_910_logistiekeverbruiksperiode_duur_dagen|| MBH_910_logistiekeverbruiksperiode_duur_dagen_MA|| MBH_910_logistiekeverbruiksperiode_duur_dagen_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top;|style="background-color: white;"
|colspan="2"|Relatie naar medicatieafspraak
+
|9.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Herhalingen</span></div>|| MBH_910_herhalingen|| MBH_910_herhalingen_MA|| MBH_910_herhalingen_VV
|style="background-color: white;"|MBH_910_start_eind_MA
+
|-style="vertical-align:top;|style="background-color: white;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|9.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Afleverlocatie</span></div>|| MBH_910_afleverlocatie|| MBH_910_afleverlocatie_MA|| MBH_910_afleverlocatie_VV
|colspan="2"|MBH identificatie
+
|}
|style="background-color: white;"|MBH_910_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
<section end=overview-VOO-9 />
|}<section end=mbhs-mv-Scenarioset1-MBH_910_start_eind-1 /><section end=mv-Scenarioset1-MBH_910_start_eind-1 />
+
=== Scenarioset 10===
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_duur==
+
<section begin=overview-VOO-10 />
<section begin=mv-Scenarioset1-MBH_910_start_duur-2 /><section begin=patient-mv-Scenarioset1-MBH_910_start_duur-2 />
+
{| class="wikitable"
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|10.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">HPK geneesmiddel</span></div>|| MBH_910_HPKvoorschrijven|| MBH_910_HPKvoorschrijven_MA|| MBH_910_HPKvoorschrijven_VV
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|10.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">ZI-nr geneesmiddel</span></div>|| MBH_910_ZINRvoorschrijven|| MBH_910_ZINRvoorschrijven_MA|| MBH_910_ZINRvoorschrijven_VV
 +
|}
 +
<section end=overview-VOO-10 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_eind==
 +
<section begin=mv-mvr-Scenarioset1-MBH_910_start_eind-1 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_start_eind-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 325: Regel 361:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset1-MBH_910_start_duur-2 /><section begin=mbhs-mv-Scenarioset1-MBH_910_start_duur-2 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_start_eind-1 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_start_eind-1 />
==== Scenario 1.2a* - MBH_910_start_duur====
+
==== Scenario 1.1 - MBH_910_start_eind====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_start_eind_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 336: Regel 372:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 11:30:00 uur
+
|style="background-color: white;"|T om 11:20:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 3 weken''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksduur
+
|colspan="4"|Einddatum
|style="background-color: white;"|3 weken
+
|style="background-color: white;"|T + 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 383: Regel 419:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Metoclopramide tablet 10mg (code = '6947' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Metoclopramide tablet 10mg (code = '19429' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 393: Regel 429:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 402: Regel 438:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_start_eind_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 412: Regel 448:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 11:30:00 uur
+
|style="background-color: white;"|T om 11:20:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 421: Regel 457:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|21 stuks
+
|style="background-color: white;"|5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Metoclopramide tablet 10mg (code = '6947' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Metoclopramide tablet 10mg (code = '19429' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 433: Regel 469:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_start_duur_MA
+
|style="background-color: white;"|MBH_910_start_eind_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset1-MBH_910_start_duur-2 /><section end=mv-Scenarioset1-MBH_910_start_duur-2 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_start_eind-1 /><section end=mv-mvr-Scenarioset1-MBH_910_start_eind-1 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_duur2==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_duur==
<section begin=mv-Scenarioset1-MBH_910_start_duur2-5 /><section begin=patient-mv-Scenarioset1-MBH_910_start_duur2-5 />
+
<section begin=mv-mvr-Scenarioset1-MBH_910_start_duur-2 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_start_duur-2 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 458: Regel 494:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset1-MBH_910_start_duur2-5 /><section begin=mbhs-mv-Scenarioset1-MBH_910_start_duur2-5 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_start_duur-2 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_start_duur-2 />
==== Scenario 1.2b* - MBH_910_start_duur2====
+
==== Scenario 1.2a optioneel - MBH_910_start_duur====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_start_duur_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 469: Regel 505:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
Regel 475: Regel 511:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 3 weken''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Gebruiksduur
 
|colspan="4"|Gebruiksduur
|style="background-color: white;"|28 dagen
+
|style="background-color: white;"|3 weken
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 500: Regel 536:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|Huisarts, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT')
+
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 516: Regel 552:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 526: Regel 562:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 535: Regel 571:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_start_duur_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 545: Regel 581:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
Regel 551: Regel 587:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
|style="background-color: white;"|Peter van Pulveren - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|28 stuks
+
|style="background-color: white;"|21 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-standaard PRK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-standaard GPK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 566: Regel 602:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_start_duur2_MA
+
|style="background-color: white;"|MBH_910_start_duur_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset1-MBH_910_start_duur2-5 /><section end=mv-Scenarioset1-MBH_910_start_duur2-5 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_start_duur-2 /><section end=mv-mvr-Scenarioset1-MBH_910_start_duur-2 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_chronisch==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_start_duur2==
<section begin=mv-Scenarioset1-MBH_910_chronisch-3 /><section begin=patient-mv-Scenarioset1-MBH_910_chronisch-3 />
+
<section begin=mv-mvr-Scenarioset1-MBH_910_start_duur2-5 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_start_duur2-5 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 591: Regel 627:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset1-MBH_910_chronisch-3 /><section begin=mbhs-mv-Scenarioset1-MBH_910_chronisch-3 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_start_duur2-5 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_start_duur2-5 />
==== Scenario 1.3 - MBH_910_chronisch====
+
==== Scenario 1.2b optioneel - MBH_910_start_duur2====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_start_duur2_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 602: Regel 638:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 11:32:00 uur
+
|style="background-color: white;"|T om 11:30:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Gebruiksduur
 +
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 630: Regel 669:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
+
|style="background-color: white;"|Huisarts, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 646: Regel 685:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 656: Regel 695:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 665: Regel 704:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_start_duur2_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 675: Regel 714:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 11:32:00 uur
+
|style="background-color: white;"|T om 11:30:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|style="background-color: white;"|Peter van Pulveren - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|21 stuks
+
|style="background-color: white;"|28 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 696: Regel 735:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_chronisch_MA
+
|style="background-color: white;"|MBH_910_start_duur2_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset1-MBH_910_chronisch-3 /><section end=mv-Scenarioset1-MBH_910_chronisch-3 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_start_duur2-5 /><section end=mv-mvr-Scenarioset1-MBH_910_start_duur2-5 />
 
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_chronisch==
 
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_chronisch==
<section begin=mv-Scenarioset1-MBH_910_chronisch-4 /><section begin=patient-mv-Scenarioset1-MBH_910_chronisch-4 />
+
<section begin=mv-mvr-Scenarioset1-MBH_910_chronisch-3 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_chronisch-3 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 721: Regel 760:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset1-MBH_910_chronisch-4 /><section begin=mbhs-mv-Scenarioset1-MBH_910_chronisch-4 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_chronisch-3 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_chronisch-3 />
==== Scenario 1.4 - MBH_910_chronisch====
+
==== Scenario 1.3 - MBH_910_chronisch====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_chronisch_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 743: Regel 782:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 798: Regel 837:
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_chronisch_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 805: Regel 844:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 11:35:00 uur
+
|style="background-color: white;"|T om 11:32:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 814: Regel 853:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|90 stuks
+
|style="background-color: white;"|21 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
Regel 830: Regel 869:
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
 
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset1-MBH_910_chronisch-4 /><section end=mv-Scenarioset1-MBH_910_chronisch-4 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_chronisch-3 /><section end=mv-mvr-Scenarioset1-MBH_910_chronisch-3 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_dosis_stuks==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_chronisch==
<section begin=mv-Scenarioset1-MBH_910_dosis_stuks-6 /><section begin=patient-mv-Scenarioset1-MBH_910_dosis_stuks-6 />
+
<section begin=mv-mvr-Scenarioset1-MBH_910_chronisch-4 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_chronisch-4 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 851: Regel 890:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset1-MBH_910_dosis_stuks-6 /><section begin=mbhs-mv-Scenarioset1-MBH_910_dosis_stuks-6 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_chronisch-4 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_chronisch-4 />
==== Scenario 1.5 - MBH_910_dosis_stuks====
+
==== Scenario 1.4 - MBH_910_chronisch====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_chronisch_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 862: Regel 901:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 11:35:00 uur
+
|style="background-color: white;"|T om 11:32:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 890: Regel 926:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
+
|style="background-color: white;"|Peter van Pulver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|Huisarts, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT')
+
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 909: Regel 945:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 919: Regel 955:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 1 dosis, inhalatie
+
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_chronisch_VV_extraVVbestaandeMA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 938: Regel 974:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
Regel 947: Regel 983:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|1 stuk
+
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 959: Regel 995:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_dosis_stuks_MA
+
|style="background-color: white;"|MBH_910_chronisch_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset1-MBH_910_dosis_stuks-6 /><section end=mv-Scenarioset1-MBH_910_dosis_stuks-6 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_chronisch-4 /><section end=mv-mvr-Scenarioset1-MBH_910_chronisch-4 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_aanvullendeinstructie==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_910_dosis_stuks==
<section begin=mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section begin=patient-mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
+
<section begin=mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 /><section begin=patient-mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 974: Regel 1.010:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|colspan="2"|Naamgegevens
|style="background-color: white;"|C. XXX_Vonker
+
|style="background-color: white;"|A. van de XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|colspan="2"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
+
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|colspan="2"|Geboortedatum
|style="background-color: white;"|8 feb 1954
+
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section begin=mbhs-mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
+
|}<section end=patient-mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 />
==== Scenario 2.1 - MBH_910_aanvullendeinstructie====
+
==== Scenario 1.5 - MBH_910_dosis_stuks====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_dosis_stuks_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 995: Regel 1.031:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:00:00 uur
+
|style="background-color: white;"|T om 11:35:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 29 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 12 maanden om 23:59:59 uur
+
|style="background-color: white;"|T + 29 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.020: Regel 1.056:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Zorgverlener identificatienummer
 
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
+
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Peter van Pulver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
+
|style="background-color: white;"|Huisarts, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 1.042: Regel 1.078:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 29 dagen, 2 maal per dag 1 dosis, inhalatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Aanvullende instructie
 
|style="background-color: white;"|Bij het eten innemen overig (code = 'OTH' in codeSystem 'HL7 NullFlavor')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|2 maal per dag 1 dosis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_dosis_stuks_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 1.074: Regel 1.107:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:00:00 uur
+
|style="background-color: white;"|T om 11:35:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|90 stuks
+
|style="background-color: white;"|1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 1.095: Regel 1.128:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA
+
|style="background-color: white;"|MBH_910_dosis_stuks_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section end=mv-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
+
|}<section end=mbhs-mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 /><section end=mv-mvr-Scenarioset1-MBH_910_dosis_stuks-6 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_toelichting==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_aanvullendeinstructie==
<section begin=mv-Scenarioset2-MBH_910_toelichting-2 /><section begin=patient-mv-Scenarioset2-MBH_910_toelichting-2 />
+
<section begin=mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section begin=patient-mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 1.120: Regel 1.153:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset2-MBH_910_toelichting-2 /><section begin=mbhs-mv-Scenarioset2-MBH_910_toelichting-2 />
+
|}<section end=patient-mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
==== Scenario 2.2 - MBH_910_toelichting====
+
==== Scenario 2.1 - MBH_910_aanvullendeinstructie====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_aanvullendeinstructie_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.131: Regel 1.164:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:02:00 uur
+
|style="background-color: white;"|T om 08:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Einddatum
 +
|style="background-color: white;"|T + 12 maanden
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.175: Regel 1.211:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Aanvullende instructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Toelichting
 
|style="background-color: white;"|In overleg met specialist
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_aanvullendeinstructie_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 1.207: Regel 1.243:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:02:00 uur
+
|style="background-color: white;"|T om 08:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 1.216: Regel 1.252:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|180 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toelichting
 
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_toelichting_MA
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset2-MBH_910_toelichting-2 /><section end=mv-Scenarioset2-MBH_910_toelichting-2 />
+
|}<section end=mbhs-mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 /><section end=mv-mvr-Scenarioset2-MBH_910_aanvullendeinstructie-1 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_redenvanvoorschrijven==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_toelichting==
<section begin=mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section begin=patient-mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
+
<section begin=mv-mvr-Scenarioset2-MBH_910_toelichting-2 /><section begin=patient-mv-mvr-Scenarioset2-MBH_910_toelichting-2 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 1.256: Regel 1.289:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section begin=mbhs-mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
+
|}<section end=patient-mv-mvr-Scenarioset2-MBH_910_toelichting-2 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_910_toelichting-2 />
==== Scenario 2.3 - MBH_910_redenvanvoorschrijven====
+
==== Scenario 2.2 - MBH_910_toelichting====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_toelichting_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.267: Regel 1.300:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:05:00 uur
+
|style="background-color: white;"|T om 08:02:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.314: Regel 1.344:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 1.324: Regel 1.354:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 1 maal per week 5 stuks, Oraal
+
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 1.330: Regel 1.360:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per week 5 stuks
+
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Toelichting
 +
|style="background-color: white;"|In overleg met specialist
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_toelichting_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 1.343: Regel 1.376:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:05:00 uur
+
|style="background-color: white;"|T om 08:02:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 1.352: Regel 1.385:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|20 stuks
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toelichting
 +
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA
+
|style="background-color: white;"|MBH_910_toelichting_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section end=mv-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
+
|}<section end=mbhs-mv-mvr-Scenarioset2-MBH_910_toelichting-2 /><section end=mv-mvr-Scenarioset2-MBH_910_toelichting-2 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_aanvullendeinformatiewensen - MBH_910_Toedieningsweg==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_redenvanvoorschrijven==
<section begin=mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section begin=patient-mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
+
<section begin=mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section begin=patient-mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 1.389: Regel 1.425:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section begin=mbhs-mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
+
|}<section end=patient-mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
==== Scenario 2.4 - MBH_910_aanvullendeinformatiewensen====
+
==== Scenario 2.3 - MBH_910_redenvanvoorschrijven====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_redenvanvoorschrijven_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.400: Regel 1.436:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:06:00 uur
+
|style="background-color: white;"|T om 08:05:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 11 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T + 1 dag om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 11 dagen om 23:59:59 uur
+
|style="background-color: white;"|T + 27 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.447: Regel 1.483:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 1.457: Regel 1.493:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 11 dagen, 3 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, 1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 1.463: Regel 1.499:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per week 5 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Aanvullende informatie
 
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_redenvanvoorschrijven_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 1.479: Regel 1.512:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:06:00 uur
+
|style="background-color: white;"|T om 08:05:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 1.488: Regel 1.521:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|20 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende wensen
 
|style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
+
|}<section end=mbhs-mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 /><section end=mv-mvr-Scenarioset2-MBH_910_redenvanvoorschrijven-3 />
==== Scenario 2.4 - MBH_910_Toedieningsweg====
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_910_aanvullendeinformatiewensen - MBH_910_Toedieningsweg==
 +
<section begin=mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section begin=patient-mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Naamgegevens
 +
|style="background-color: white;"|C. XXX_Vonker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatienummer
 +
|style="background-color: white;"|999910401 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geboortedatum
 +
|style="background-color: white;"|8 feb 1954
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 +
|}<section end=patient-mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
 +
==== Scenario 2.4 - MBH_910_aanvullendeinformatiewensen====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_aanvullendeinformatiewensen_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.518: Regel 1.569:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:15:00 uur
+
|style="background-color: white;"|T om 08:06:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 10 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 7 dagen om 23:59:59 uur
+
|style="background-color: white;"|T + 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.546: Regel 1.597:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 1.565: Regel 1.616:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
+
|style="background-color: white;"|Vanaf T, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Aanvullende instructie
 
|style="background-color: white;"|In het rechter oog overig (code = 'OTH' in codeSystem 'HL7 NullFlavor')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 druppel
+
|style="background-color: white;"|3 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Aanvullende informatie
 
|colspan="5"|Aanvullende informatie
|style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
+
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_aanvullendeinformatiewensen_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 1.600: Regel 1.648:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:15:00 uur
+
|style="background-color: white;"|T om 08:06:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 1.609: Regel 1.657:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|14 druppels
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Aanvullende wensen
 +
|style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_Toedieningsweg_MA
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section end=mv-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_aanvullendeinstructie==
+
==== Scenario 2.4 - MBH_910_Toedieningsweg====
<section begin=mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section begin=patient-mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|style="background-color: white;"|C. XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section begin=mbhs-mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
 
==== Scenario 3.1 - MBH_910_aanvullendeinstructie====
 
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_Toedieningsweg_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.657: Regel 1.687:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 18:00:00 uur
+
|style="background-color: white;"|T om 08:15:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T om 23:59:59 uur
+
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Stoptype
 
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
 
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.691: Regel 1.715:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 1.708: Regel 1.732:
 
|colspan="2"|Adresgegevens
 
|colspan="2"|Adresgegevens
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Reden wijzigen of staken
 
|style="background-color: white;"|Overgevoeligheid (code = '16' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 1.723: Regel 1.744:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Aanvullende instructie
 
|colspan="4"|Aanvullende instructie
|style="background-color: white;"|Bij het eten innemen overig (code = 'OTH' in codeSystem 'HL7 NullFlavor')
+
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|2 maal per dag 1 druppel
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Aanvullende informatie
 +
|style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section end=mv-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_toelichting==
+
{| class="wikitable" width="85%"
<section begin=mv-Scenarioset3-MBH_910_toelichting-2 /><section begin=patient-mv-Scenarioset3-MBH_910_toelichting-2 />
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_Toedieningsweg_VV
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_910_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Datum
 +
|style="background-color: white;"|T om 08:15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Auteur
 +
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Te verstrekken hoeveelheid
 +
|style="background-color: white;"|14 druppels
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Beoogd verstrekker
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Relatie naar medicatieafspraak
 +
|style="background-color: white;"|MBH_910_Toedieningsweg_MA
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|MBH identificatie
 +
|style="background-color: white;"|MBH_910_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}<section end=mbhs-mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 /><section end=mv-mvr-Scenarioset2-MBH_910_aanvullendeinformatiewensen-4 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_aanvullendeinstructie==
 +
<section begin=mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section begin=patient-mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 1.757: Regel 1.815:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset3-MBH_910_toelichting-2 /><section begin=mbhs-mv-Scenarioset3-MBH_910_toelichting-2 />
+
|}<section end=patient-mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
==== Scenario 3.2 - MBH_910_toelichting====
+
==== Scenario 3.1 - MBH_910_aanvullendeinstructie====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_aanvullendeinstructie_MA_staken
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.768: Regel 1.826:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 18:02:00 uur
+
|style="background-color: white;"|T om 18:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T om 19:00:00 uur''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 1 dag''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 19:00:00 uur
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Einddatum
 +
|style="background-color: white;"|T + 1 dag
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Stoptype
 +
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
|style="background-color: white;"|MBH_910_toelichting_MA
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 1.815: Regel 1.879:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Reden wijzigen of staken
 
|colspan="5"|Reden wijzigen of staken
|style="background-color: white;"|Geen of onvoldoende effect (code = '58848006' in codeSystem 'SNOMED CT')
+
|style="background-color: white;"|Overgevoeligheid (code = '16' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T om 19:00:00 uur, 1 maal per dag 2 stuks, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 1 dag, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Aanvullende instructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
+
|}<section end=mbhs-mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 /><section end=mv-mvr-Scenarioset3-MBH_910_aanvullendeinstructie-1 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_toelichting==
 +
<section begin=mv-mvr-Scenarioset3-MBH_910_toelichting-2 /><section begin=patient-mv-mvr-Scenarioset3-MBH_910_toelichting-2 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Naamgegevens
 +
|style="background-color: white;"|C. XXX_Vonker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatienummer
 +
|style="background-color: white;"|999910401 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geboortedatum
 +
|style="background-color: white;"|8 feb 1954
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 +
|}<section end=patient-mv-mvr-Scenarioset3-MBH_910_toelichting-2 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_910_toelichting-2 />
 +
==== Scenario 3.2 - MBH_910_toelichting====
 +
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_toelichting_MA_wijzigingmetVV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 1.847: Regel 1.937:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 18:02:00 uur
+
|style="background-color: white;"|T om 08:02:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 19:00:00 uur''
+
|style="background-color: #E3E3E3;;"|''Vanaf T om 09:00:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T om 19:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Stoptype
 
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
Regel 1.881: Regel 1.965:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|(code = 'UNK' in codeSystem 'HL7 NullFlavor')
+
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 1.898: Regel 1.982:
 
|colspan="2"|Adresgegevens
 
|colspan="2"|Adresgegevens
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Reden wijzigen of staken
 +
|style="background-color: white;"|Contra-indicatie (code = '438833006' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
Regel 1.910: Regel 1.997:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T om 19:00:00 uur, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T om 09:00:00 uur, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
Regel 1.922: Regel 2.009:
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_toelichting_MA_techstaken
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="2" width="25%"| Gegevenselement
+
|colspan="5" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
+
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_toelichting_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Datum
+
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 18:02:00 uur
+
|style="background-color: white;"|T om 08:02:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 09:00:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur
+
|rowspan="3"|
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Te verstrekken hoeveelheid
+
|colspan="4"|Ingangsdatum
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geneesmiddel - primaire code
+
|colspan="4"|Einddatum
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|T om 09:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geneesmiddel - generiekere code
+
|colspan="5"|Stoptype
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Beoogd verstrekker
+
|colspan="5"|Relatie naar afspraak of gebruik: MA
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|style="background-color: white;"|MBH_910_toelichting_MA
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="6"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Relatie naar medicatieafspraak
+
|rowspan="11"|
|style="background-color: white;"|MBH_910_toelichting_MA_wijzigingmetVV
+
|-style="vertical-align:top; background-color: #E3E3E3;;
 +
|colspan="5"|Zorgverlener
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|MBH identificatie
+
|rowspan="9"|
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mv-Scenarioset3-MBH_910_toelichting-2 /><section end=mv-Scenarioset3-MBH_910_toelichting-2 />
 
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_redenvanvoorschrijven==
 
<section begin=mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section begin=patient-mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|style="background-color: white;"|C. XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section begin=mbhs-mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
 
==== Scenario 3.3 - MBH_910_redenvanvoorschrijven====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="5" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|style="background-color: white;"|T om 18:10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|style="background-color: white;"|T om 00:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="6"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="11"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Zorgverlener
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="9"|
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Zorgverlener identificatienummer
 
|colspan="3"|Zorgverlener identificatienummer
Regel 2.014: Regel 2.050:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 2.032: Regel 2.068:
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Reden wijzigen of staken
+
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Ander voorschrijfbeleid (code = '112751000146109' in codeSystem 'SNOMED CT')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.046: Regel 2.079:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T om 09:00:00 uur, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per week 4 stuks
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_toelichting_VV_extra
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="5" width="25%"| Gegevenselement
+
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
+
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_toelichting_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraak datum tijd
+
|colspan="2"|Datum
|style="background-color: white;"|T om 18:10:00 uur
+
|style="background-color: white;"|T om 08:02:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 19:00:00 uur''
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|colspan="2"|Auteur
 +
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
+
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|60 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Einddatum
+
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|T om 19:00:00 uur
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Stoptype
+
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie naar afspraak of gebruik: MA
+
|colspan="2"|Beoogd verstrekker
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA
+
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="6"|Voorschrijver
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
+
|colspan="2"|Relatie naar medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;
+
|style="background-color: white;"|MBH_910_toelichting_MA_wijzigingmetVV
|colspan="5"|Zorgverlener
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="9"|
+
|colspan="2"|MBH identificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|style="background-color: white;"|MBH_910_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|colspan="3"|Zorgverlener identificatienummer
+
|}<section end=mbhs-mv-mvr-Scenarioset3-MBH_910_toelichting-2 /><section end=mv-mvr-Scenarioset3-MBH_910_toelichting-2 />
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_redenvanvoorschrijven==
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
<section begin=mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section begin=patient-mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
|colspan="3"|Naamgegevens
 
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Zorgaanbieder
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder identificatienummer
 
|style="background-color: white;"|00001111 (in identificerend systeem: UZI Personen)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Organisatie naam
 
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Adresgegevens
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T om 19:00:00 uur, 1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|style="background-color: white;"|1 maal per week 5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section end=mv-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
 
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_aanvullendeinformatiewensen==
 
<section begin=mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section begin=patient-mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 2.159: Regel 2.144:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section begin=mbhs-mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
+
|}<section end=patient-mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
==== Scenario 3.4 optioneel - MBH_910_aanvullendeinformatiewensen====
+
==== Scenario 3.3 - MBH_910_redenvanvoorschrijven====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 2.170: Regel 2.155:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 18:12:00 uur
+
|style="background-color: white;"|T om 08:10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 1 dag''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 6 dagen, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T + 1 dag om 00:00:00 uur
+
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 1 dag om 23:59:59 uur
+
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Stoptype
 
|style="background-color: white;"|Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). (code = '112171000146100' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Relatie naar afspraak of gebruik: MA
 
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.204: Regel 2.183:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
|style="background-color: white;"|(code = 'UNK' in codeSystem 'HL7 NullFlavor')
+
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Zorgaanbieder
 
|colspan="4"|Zorgaanbieder
Regel 2.223: Regel 2.202:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Reden wijzigen of staken
 
|colspan="5"|Reden wijzigen of staken
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
+
|style="background-color: white;"|Ander voorschrijfbeleid (code = '112751000146109' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.236: Regel 2.215:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 1 dag, 3 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T + 6 dagen, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per week 4 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Aanvullende informatie
 
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section end=mv-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 4a (Lengte Gewicht) - MBH_910_Lengte_Gewicht==
 
<section begin=mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section begin=patient-mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|style="background-color: white;"|A. XXX_Molenaars
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|style="background-color: white;"|999910449 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section begin=mbhs-mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 
==== Scenario 4.1* - MBH_910_Lengte_Gewicht====
 
 
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_redenvanvoorschrijven_MA_techstaken
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 2.281: Regel 2.234:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|T om 08:10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 1 jaar''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 6 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksduur
+
|colspan="4"|Einddatum
|style="background-color: white;"|1 jaar
+
|style="background-color: white;"|T + 6 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Stoptype
 +
|style="background-color: white;"|Het staken van een bestaande medicamenteuze behandeling. (code = '112161000146106' in codeSystem 'SNOMED CT')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Relatie naar afspraak of gebruik: MA
 +
|style="background-color: white;"|MBH_910_redenvanvoorschrijven_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.306: Regel 2.265:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Zorgverlener identificatienummer
 
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
+
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 2.328: Regel 2.287:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.338: Regel 2.297:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, gedurende 1 jaar, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 6 dagen, 1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 2.344: Regel 2.303:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per week 5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
+
|}<section end=mbhs-mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 /><section end=mv-mvr-Scenarioset3-MBH_910_redenvanvoorschrijven-3 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_910_aanvullendeinformatiewensen==
 +
<section begin=mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section begin=patient-mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 2.356: Regel 2.317:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
+
|colspan="2"|Naamgegevens
|style="background-color: white;"|MBH_910_Lengte_Gewicht_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|C. XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Datum
+
|colspan="2"|Identificatienummer
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur
+
|colspan="2"|Geboortedatum
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Te verstrekken hoeveelheid
+
|colspan="2"|Geslacht
|style="background-color: white;"|180 stuks
+
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|}<section end=patient-mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
|colspan="2"|Geneesmiddel - primaire code
+
==== Scenario 3.4 optioneel - MBH_910_aanvullendeinformatiewensen====
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|style="background-color: white;"|MBH_910_Lengte_Gewicht_MA_1
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|style="background-color: white;"|MBH_910_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Lichaamslengte ====
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Lichaamslengte
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_aanvullendeinformatiewensen_MA_onderbreken
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="2" width="25%"| Gegevenselement
+
|colspan="5" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Lengte waarde
+
|colspan="5"|Identificatie
|style="background-color: white;"|155 cm
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Lengte datum tijd
 
|style="background-color: white;"|T om 07:05:00 uur
 
|}
 
==== Lichaamsgewicht ====
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Lichaamsgewicht
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gewicht waarde
 
|style="background-color: white;"|54 kg
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gewicht datum tijd
 
|style="background-color: white;"|T om 07:05:00 uur
 
|}<section end=mbhs-mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section end=mv-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 4b (Lengte Gewicht ID) - MBH_910_Lengte_Gewicht_Persistent==
 
<section begin=mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section begin=patient-mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|style="background-color: white;"|A. XXX_Molenaars
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|style="background-color: white;"|999910449 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section begin=mbhs-mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
 
==== Scenario 4.2* - MBH_910_Lengte_Gewicht_Persistent====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="5" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|T om 18:12:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 1 jaar''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 15:00:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksduur
+
|colspan="4"|Einddatum
|style="background-color: white;"|1 jaar
+
|style="background-color: white;"|T om 15:00:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Stoptype
 +
|style="background-color: white;"|Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). (code = '112171000146100' in codeSystem 'SNOMED CT')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Relatie naar afspraak of gebruik: MA
 +
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.467: Regel 2.370:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Zorgverlener identificatienummer
 
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
+
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
+
|style="background-color: white;"|Bertine van Doorn
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 2.487: Regel 2.390:
 
|colspan="2"|Adresgegevens
 
|colspan="2"|Adresgegevens
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Reden wijzigen of staken
 +
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.499: Regel 2.405:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, gedurende 1 jaar, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T om 15:00:00 uur, 3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 2.505: Regel 2.411:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|3 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Aanvullende informatie
 +
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
+
|}<section end=mbhs-mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 /><section end=mv-mvr-Scenarioset3-MBH_910_aanvullendeinformatiewensen-4 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 4a (Lengte Gewicht) - MBH_910_Lengte_Gewicht==
 +
<section begin=mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section begin=patient-mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 2.517: Regel 2.428:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
+
|colspan="2"|Naamgegevens
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|A. XXX_Molenaars
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Datum
+
|colspan="2"|Identificatienummer
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|999910449 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur
+
|colspan="2"|Geboortedatum
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
+
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Te verstrekken hoeveelheid
+
|colspan="2"|Geslacht
|style="background-color: white;"|180 stuks
+
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 +
|}<section end=patient-mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section begin=mbhs-mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 +
==== Scenario 4.1* - MBH_910_Lengte_Gewicht====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_Lengte_Gewicht_MA_1
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="5" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geneesmiddel - primaire code
+
|colspan="5"|Identificatie
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geneesmiddel - generiekere code
+
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|T om 07:05:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;
 +
|colspan="5"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Beoogd verstrekker
+
|rowspan="2"|
|style="background-color: white;"|Apotheek De Gulle Gaper
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Relatie naar medicatieafspraak
+
|colspan="4"|Ingangsdatum
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_MA
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="6"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|MBH identificatie
+
|rowspan="11"|
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Lichaamslengte ====
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Lichaamslengte
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zibroot
+
|colspan="5"|Zorgverlener
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|rowspan="9"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
+
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_Lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1)
+
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Lengte waarde
+
|colspan="3"|Naamgegevens
|style="background-color: white;"|155 cm
+
|style="background-color: white;"|Peter van Pulver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Lengte datum tijd
+
|colspan="3"|Specialisme
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|}
+
|-style="vertical-align:top; background-color: #E3E3E3;;" 
==== Lichaamsgewicht ====
+
|colspan="4"|Zorgaanbieder
{| class="wikitable" width="85%"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Lichaamsgewicht
+
|rowspan="4"|
|-style="background-color: #1F497D;; color: white; text-align:left;"  
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3" width="25%"| Gegevenselement
+
|colspan="2"|Zorgaanbieder identificatienummer
|| Waarde
+
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
 
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Organisatie naam
 +
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zibroot
+
|colspan="6"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|colspan="4"|Omschrijving
 +
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
+
|colspan="4"|Toedieningsweg
|style="background-color: white;"|MBH_910_Lengte_Gewicht _Persistent_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1)
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gewicht waarde
+
|colspan="4"|Doseerinstructie
|style="background-color: white;"|54 kg
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gewicht datum tijd
+
|colspan="5"|MBH identificatie
|style="background-color: white;"|T om 07:05:00 uur
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section end=mv-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 5a (Nierfunctie) - MBH_910_Nierfunctie==
 
<section begin=mv-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section begin=patient-mv-Scenarioset5_a-MBH_910_Nierfunctie-1 />
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_Lengte_Gewicht_VV_1
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 2.595: Regel 2.522:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Naamgegevens
+
|colspan="2"|Identificatie
|style="background-color: white;"|A. XXX_Molenaars
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
+
|colspan="2"|Datum
|style="background-color: white;"|999910449 [BSN]
+
|style="background-color: white;"|T om 07:05:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geboortedatum
+
|colspan="2"|Auteur
|style="background-color: white;"|8 jun 1954
+
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Te verstrekken hoeveelheid
 +
|style="background-color: white;"|180 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Beoogd verstrekker
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Relatie naar medicatieafspraak
 +
|style="background-color: white;"|MBH_910_Lengte_Gewicht_MA_1
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geslacht
+
|colspan="2"|MBH identificatie
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=patient-mv-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section begin=mbhs-mv-Scenarioset5_a-MBH_910_Nierfunctie-1 />
+
|}
==== Scenario 5.1* - MBH_910_Nierfunctie====
+
==== Lichaamslengte ====
 
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Lichaamslengte
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="5" width="25%"| Gegevenselement
+
|colspan="2" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
+
|colspan="2"|Lengte waarde
|style="background-color: white;"|MBH_910_Nierfunctie_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|155 cm
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraak datum tijd
+
|colspan="2"|Lengte datum tijd
|style="background-color: white;"|T om 07:00:00 uur
+
|style="background-color: white;"|T om 07:05:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
+
|}
|colspan="5"|Gebruiksperiode
+
==== Lichaamsgewicht ====
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Lichaamsgewicht
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|colspan="2"|Gewicht waarde
 +
|style="background-color: white;"|54 kg
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
+
|colspan="2"|Gewicht datum tijd
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T om 07:05:00 uur
 +
|}<section end=mbhs-mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 /><section end=mv-mvr-Scenarioset4_a-MBH_910_Lengte_Gewicht-1 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 4b (Lengte Gewicht ID) - MBH_910_Lengte_Gewicht_Persistent==
 +
<section begin=mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section begin=patient-mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Naamgegevens
 +
|style="background-color: white;"|A. XXX_Molenaars
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatienummer
 +
|style="background-color: white;"|999910449 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geboortedatum
 +
|style="background-color: white;"|8 jun 1954
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 +
|}<section end=patient-mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section begin=mbhs-mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
 +
==== Scenario 4.2* - MBH_910_Lengte_Gewicht_Persistent====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_Lengte_Gewicht_Persistent_MA
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="5" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Identificatie
 +
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="5"|Afspraak datum tijd
 +
|style="background-color: white;"|T om 07:05:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 245 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Einddatum
 +
|style="background-color: white;"|T + 245 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.661: Regel 2.655:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.671: Regel 2.665:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, 2 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 245 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
Regel 2.677: Regel 2.671:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_Lengte_Gewicht_Persistent_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 2.690: Regel 2.684:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_Nierfunctie_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 07:00:00 uur
+
|style="background-color: white;"|T om 07:05:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 2.699: Regel 2.693:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|120 stuks
+
|style="background-color: white;"|125 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 2.711: Regel 2.705:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_Nierfunctie_MA_1
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
==== Laboratorium uitslag ====
+
==== Lichaamslengte ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Laboratorium uitslag
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Lichaamslengte
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.724: Regel 2.718:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Laboratorium test
+
|colspan="4"|Zibroot
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Test code
+
|colspan="2"|Identificatienummer
|style="background-color: white;"|Creatinine renal clearance predicted by Cockcroft-Gault formula (code = '35591-7' in codeSystem 'LOINC')
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht_Persistent_Lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Test datum tijd
+
|colspan="3"|Lengte waarde
|style="background-color: white;"|T - 12 dagen om 11:00:00 uur
+
|style="background-color: white;"|155 cm
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Test uitslag
+
|colspan="3"|Lengte datum tijd
|style="background-color: white;"|38 ml/min
+
|style="background-color: white;"|T om 07:05:00 uur
|}<section end=mbhs-mv-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section end=mv-Scenarioset5_a-MBH_910_Nierfunctie-1 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 5b (Nierfunctie ID) - MBH_910_Nierfunctie_Persistent==
+
==== Lichaamsgewicht ====
<section begin=mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section begin=patient-mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Lichaamsgewicht
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="2" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Zibroot
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Naamgegevens
+
|rowspan="2"|
|style="background-color: white;"|A. XXX_Molenaars
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|colspan="2"|Identificatienummer
|style="background-color: white;"|999910449 [BSN]
+
|style="background-color: white;"|MBH_910_Lengte_Gewicht _Persistent_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geboortedatum
+
|colspan="3"|Gewicht waarde
|style="background-color: white;"|8 jun 1954
+
|style="background-color: white;"|54 kg
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Geslacht
+
|colspan="3"|Gewicht datum tijd
 +
|style="background-color: white;"|T om 07:05:00 uur
 +
|}<section end=mbhs-mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 /><section end=mv-mvr-Scenarioset4_b-MBH_910_Lengte_Gewicht_Persistent-1 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 5a (Nierfunctie) - MBH_910_Nierfunctie==
 +
<section begin=mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section begin=patient-mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="2" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Naamgegevens
 +
|style="background-color: white;"|A. XXX_Molenaars
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatienummer
 +
|style="background-color: white;"|999910449 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geboortedatum
 +
|style="background-color: white;"|8 jun 1954
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section begin=mbhs-mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
+
|}<section end=patient-mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section begin=mbhs-mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 />
==== Scenario 5.2* - MBH_910_Nierfunctie_Persistent====
+
==== Scenario 5.1* - MBH_910_Nierfunctie====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_Nierfunctie_MA_1
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 2.768: Regel 2.783:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
Regel 2.779: Regel 2.794:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.831: Regel 2.846:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_Nierfunctie_VV_1
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 2.841: Regel 2.856:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
Regel 2.862: Regel 2.877:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_MA
+
|style="background-color: white;"|MBH_910_Nierfunctie_MA_1
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Laboratorium uitslag ====
 
==== Laboratorium uitslag ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Laboratorium uitslag
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Laboratorium uitslag
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Laboratorium test
+
|colspan="4"|Laboratorium test
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
+
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Zibroot
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|colspan="2"|Test code
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|style="background-color: white;"|MBH_910_Nierfunctie _Persistent_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.24030.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Test code
 
 
|style="background-color: white;"|Creatinine renal clearance predicted by Cockcroft-Gault formula (code = '35591-7' in codeSystem 'LOINC')
 
|style="background-color: white;"|Creatinine renal clearance predicted by Cockcroft-Gault formula (code = '35591-7' in codeSystem 'LOINC')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Test datum tijd
+
|colspan="2"|Test datum tijd
 
|style="background-color: white;"|T - 12 dagen om 11:00:00 uur
 
|style="background-color: white;"|T - 12 dagen om 11:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Test uitslag
+
|colspan="2"|Test uitslag
 
|style="background-color: white;"|38 ml/min
 
|style="background-color: white;"|38 ml/min
|}<section end=mbhs-mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section end=mv-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
+
|}<section end=mbhs-mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 /><section end=mv-mvr-Scenarioset5_a-MBH_910_Nierfunctie-1 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelefrequentie==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 5b (Nierfunctie ID) - MBH_910_Nierfunctie_Persistent==
<section begin=mv-Scenarioset6-MBH_910_variabelefrequentie-1 /><section begin=patient-mv-Scenarioset6-MBH_910_variabelefrequentie-1 />
+
<section begin=mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section begin=patient-mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 2.905: Regel 2.913:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Naamgegevens
 
|colspan="2"|Naamgegevens
|style="background-color: white;"|S. XXX_Jankie
+
|style="background-color: white;"|A. XXX_Molenaars
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatienummer
 
|colspan="2"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
+
|style="background-color: white;"|999910449 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geboortedatum
 
|colspan="2"|Geboortedatum
|style="background-color: white;"|8 mei 1954
+
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_variabelefrequentie-1 /><section begin=mbhs-mv-Scenarioset6-MBH_910_variabelefrequentie-1 />
+
|}<section end=patient-mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section begin=mbhs-mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
==== Scenario 6.1 optioneel - MBH_910_variabelefrequentie====
+
==== Scenario 5.2* - MBH_910_Nierfunctie_Persistent====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_Nierfunctie_Persistent_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 2.926: Regel 2.934:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:00:00 uur
+
|style="background-color: white;"|T om 07:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T + 16 dagen om 23:59:59 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 2.954: Regel 2.959:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgegevens
 
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
+
|style="background-color: white;"|Peter van Pulver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Specialisme
 
|colspan="3"|Specialisme
Regel 2.973: Regel 2.978:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 2.983: Regel 2.988:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Vanaf T, 2 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
+
|style="background-color: white;"|2 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_Nierfunctie_Persistent_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.002: Regel 3.007:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:00:00 uur
+
|style="background-color: white;"|T om 07:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.011: Regel 3.016:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|90 stuks
+
|style="background-color: white;"|120 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-standaard PRK')
+
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-standaard GPK')
+
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 3.023: Regel 3.028:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_variabelefrequentie_MA
+
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_Nierfunctie_Persistent (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_variabelefrequentie-1 /><section end=mv-Scenarioset6-MBH_910_variabelefrequentie-1 />
+
|}
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_interval==
+
==== Laboratorium uitslag ====
<section begin=mv-Scenarioset6-MBH_910_interval-2 /><section begin=patient-mv-Scenarioset6-MBH_910_interval-2 />
+
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Laboratorium uitslag
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Laboratorium test
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Zibroot
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatienummer
 +
|style="background-color: white;"|MBH_910_Nierfunctie _Persistent_Nierfunctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.24030.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Test code
 +
|style="background-color: white;"|Creatinine renal clearance predicted by Cockcroft-Gault formula (code = '35591-7' in codeSystem 'LOINC')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Test datum tijd
 +
|style="background-color: white;"|T - 12 dagen om 11:00:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Test uitslag
 +
|style="background-color: white;"|38 ml/min
 +
|}<section end=mbhs-mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 /><section end=mv-mvr-Scenarioset5_b-MBH_910_Nierfunctie_Persistent-1 />
 +
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelefrequentie==
 +
<section begin=mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.048: Regel 3.081:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_interval-2 /><section begin=mbhs-mv-Scenarioset6-MBH_910_interval-2 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 />
==== Scenario 6.2 optioneel - MBH_910_interval====
+
==== Scenario 6.1 optioneel - MBH_910_variabelefrequentie====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_variabelefrequentie_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.059: Regel 3.092:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:04:00 uur
+
|style="background-color: white;"|T om 08:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Einddatum
 +
|style="background-color: white;"|T + 16 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 3.103: Regel 3.139:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '34851' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '111325' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 3.113: Regel 3.149:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, exact iedere 12 uur 16 internationale eenheid, subcutaan
+
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|exact iedere 12 uur 16 internationale eenheid
+
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_variabelefrequentie_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.132: Regel 3.168:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:04:00 uur
+
|style="background-color: white;"|T om 08:00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.141: Regel 3.177:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|1 stuk
+
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '34851' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '111325' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_interval_MA
+
|style="background-color: white;"|MBH_910_variabelefrequentie_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_interval-2 /><section end=mv-Scenarioset6-MBH_910_interval-2 />
+
|}<section end=mbhs-mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 /><section end=mv-mvr-Scenarioset6-MBH_910_variabelefrequentie-1 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelehoeveelheid==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_interval==
<section begin=mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section begin=patient-mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
+
<section begin=mv-mvr-Scenarioset6-MBH_910_interval-2 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_interval-2 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.178: Regel 3.214:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section begin=mbhs-mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_interval-2 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_interval-2 />
==== Scenario 6.3 optioneel - MBH_910_variabelehoeveelheid====
+
==== Scenario 6.2 optioneel - MBH_910_interval====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_interval_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.189: Regel 3.225:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:10:00 uur
+
|style="background-color: white;"|T om 08:04:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 3.236: Regel 3.269:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '34851' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '111325' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
Regel 3.246: Regel 3.279:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal
+
|style="background-color: white;"|Vanaf T, exact iedere 12 uur 16 internationale eenheid, subcutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
+
|style="background-color: white;"|exact iedere 12 uur 16 internationale eenheid
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_interval_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.265: Regel 3.298:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:10:00 uur
+
|style="background-color: white;"|T om 08:04:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.274: Regel 3.307:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|100 stuks
+
|style="background-color: white;"|1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '34851' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|INSULINE ISOFAAN 100IE/ML (code = '111325' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 3.286: Regel 3.319:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_variabelehoeveelheid_MA
+
|style="background-color: white;"|MBH_910_interval_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section end=mv-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
+
|}<section end=mbhs-mv-mvr-Scenarioset6-MBH_910_interval-2 /><section end=mv-mvr-Scenarioset6-MBH_910_interval-2 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_zonderkeerdosis==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelehoeveelheid==
<section begin=mv-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section begin=patient-mv-Scenarioset6-MBH_910_zonderkeerdosis-4 />
+
<section begin=mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.311: Regel 3.344:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section begin=mbhs-mv-Scenarioset6-MBH_910_zonderkeerdosis-4 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
==== Scenario 6.4 optioneel - MBH_910_zonderkeerdosis====
+
==== Scenario 6.3 optioneel - MBH_910_variabelehoeveelheid====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_variabelehoeveelheid_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.322: Regel 3.355:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:12:00 uur
+
|style="background-color: white;"|T om 08:10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
Regel 3.333: Regel 3.366:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
+
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 3.369: Regel 3.402:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
+
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Aanvullende instructie
 
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
+
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_variabelehoeveelheid_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.401: Regel 3.431:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:12:00 uur
+
|style="background-color: white;"|T om 08:10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.410: Regel 3.440:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|1 stuk
+
|style="background-color: white;"|100 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 3.422: Regel 3.452:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_zonderkeerdosis_MA
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section end=mv-Scenarioset6-MBH_910_zonderkeerdosis-4 />
+
|}<section end=mbhs-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 /><section end=mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid-3 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_bijzonderekeerdosis==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_zonderkeerdosis==
<section begin=mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section begin=patient-mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
+
<section begin=mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.447: Regel 3.477:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section begin=mbhs-mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 />
==== Scenario 6.5 optioneel - MBH_910_bijzonderekeerdosis====
+
==== Scenario 6.4 optioneel - MBH_910_zonderkeerdosis====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_zonderkeerdosis_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.458: Regel 3.488:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:15:00 uur
+
|style="background-color: white;"|T om 08:12:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
Regel 3.469: Regel 3.499:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
+
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 3.505: Regel 3.535:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
+
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Aanvullende instructie
 +
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|colspan="4"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 0.5 stuk
+
|style="background-color: white;"|3 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_910_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_zonderkeerdosis_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.534: Regel 3.567:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:15:00 uur
+
|style="background-color: white;"|T om 08:12:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.543: Regel 3.576:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 3.555: Regel 3.588:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_MA
+
|style="background-color: white;"|MBH_910_zonderkeerdosis_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section end=mv-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
+
|}<section end=mbhs-mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 /><section end=mv-mvr-Scenarioset6-MBH_910_zonderkeerdosis-4 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelehoeveelheid2==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_bijzonderekeerdosis==
<section begin=mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 /><section begin=patient-mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 />
+
<section begin=mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.580: Regel 3.613:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 /><section begin=mbhs-mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
==== Scenario 6.6 optioneel - MBH_910_variabelehoeveelheid2====
+
==== Scenario 6.5 optioneel - MBH_910_bijzonderekeerdosis====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_bijzonderekeerdosis_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.591: Regel 3.624:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:18:00 uur
+
|style="background-color: white;"|T om 08:15:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
Regel 3.602: Regel 3.635:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 28 dagen om 23:59:59 uur
+
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Voorschrijver
 
|colspan="6"|Voorschrijver
Regel 3.638: Regel 3.671:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - primaire code
 
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Geneesmiddel - generiekere code
 
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '116041' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="6"|Gebruiksinstructie
 
|colspan="6"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Omschrijving
 
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen
+
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Toedieningsweg
 
|colspan="4"|Toedieningsweg
|style="background-color: white;"|niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende instructie
+
|colspan="4"|Doseerinstructie
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
+
|style="background-color: white;"|2 maal per dag 0.5 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende instructie
+
|colspan="5"|MBH identificatie
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
+
|style="background-color: white;"|MBH_910_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 10 à 15 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|MBH identificatie
 
|style="background-color: white;"|MBH_910_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Verstrekkingsverzoek MBH_910_bijzonderekeerdosis_VV
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="2" width="25%"| Gegevenselement
 
|colspan="2" width="25%"| Gegevenselement
Regel 3.673: Regel 3.700:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
+
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Datum
 
|colspan="2"|Datum
|style="background-color: white;"|T om 08:18:00 uur
+
|style="background-color: white;"|T om 08:15:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Auteur
 
|colspan="2"|Auteur
Regel 3.682: Regel 3.709:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Te verstrekken hoeveelheid
 
|colspan="2"|Te verstrekken hoeveelheid
|style="background-color: white;"|450 ml
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - primaire code
 
|colspan="2"|Geneesmiddel - primaire code
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Geneesmiddel - generiekere code
 
|colspan="2"|Geneesmiddel - generiekere code
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '116041' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Beoogd verstrekker
 
|colspan="2"|Beoogd verstrekker
Regel 3.694: Regel 3.721:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Relatie naar medicatieafspraak
 
|colspan="2"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_910_variabelehoeveelheid2_MA
+
|style="background-color: white;"|MBH_910_bijzonderekeerdosis_MA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|MBH identificatie
 
|colspan="2"|MBH identificatie
|style="background-color: white;"|MBH_910_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_910_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 /><section end=mv-Scenarioset6-MBH_910_variabelehoeveelheid2-6 />
+
|}<section end=mbhs-mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 /><section end=mv-mvr-Scenarioset6-MBH_910_bijzonderekeerdosis-5 />
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_tijdstippen==
+
== MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_910_variabelehoeveelheid2==
<section begin=mv-Scenarioset6-MBH_910_tijdstippen-7 /><section begin=patient-mv-Scenarioset6-MBH_910_tijdstippen-7 />
+
<section begin=mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid2-6 /><section begin=patient-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid2-6 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="3" | Patiënt
Regel 3.719: Regel 3.746:
 
|colspan="2"|Geslacht
 
|colspan="2"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mv-Scenarioset6-MBH_910_tijdstippen-7 /><section begin=mbhs-mv-Scenarioset6-MBH_910_tijdstippen-7 />
+
|}<section end=patient-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid2-6 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_910_variabelehoeveelheid2-6 />
==== Scenario 6.7a* - MBH_910_tijdstippen====
+
==== Scenario 6.6 optioneel - MBH_910_variabelehoeveelheid2====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_910_variabelehoeveelheid2_MA
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="5" width="25%"| Gegevenselement
 
|colspan="5" width="25%"| Gegevenselement
Regel 3.730: Regel 3.757:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Identificatie
 
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_910_tijdstippen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_910_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="5"|Afspraak datum tijd
 
|colspan="5"|Afspraak datum tijd
|style="background-color: white;"|T om 08:24:00 uur
+
|style="background-color: white;"|T om 08:18:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="5"|Gebruiksperiode
 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Ingangsdatum
 
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T om 00:00:00 uur
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Einddatum
 
|colspan="4"|Einddatum
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
+
|style="background-color: white;"|T +